Preclinical Studies Reveal Mechanisms Behind Limited Efficacy of Umbilical Cord Derived Mesenchymal Stem Cells in Lung Regeneration

Strategic Insights -

Preclinical studies have long sought to understand the therapeutic potential of umbilical cord derived mesenchymal stem cells (UC-MSC) in lung regeneration. Recent research has provided convincing evidence that UC-MSC can prevent lung injury and promote lung regeneration. However, their limited therapeutic efficacy within clinics has been a long-standing concern. Current studies suggest that cyclic mechanical stretch (CMS) and hyperoxia (HOX) during mechanical ventilation may account for this limited efficacy. Research from the German Center for Lung Research (DZL) has shed light on the mechanisms behind this phenomenon.

Key Takeaways:

  • UC-MSC cultures subjected to CMS and HOX experienced compromised cell viability and proliferation, altered phenotypic characteristics, and induced cellular senescence.
  • Effects of CMS and HOX were most pronounced when both were applied together, compromising cell viability and proliferation, and altering phenotypic characteristics.
  • The alterations of UC-MSC were mediated by p21 accumulation, which was further underpinned by the principal reversibility of the phenotype alterations and regrowth after removal of CMS and HOX.
  • However, prolonged exposure resulted in definite phenotype changes, suggesting a potential mechanism for the limited efficacy of UC-MSC in clinical settings.
  • The study suggests that future research should focus on the repetitive application of UC-MSC to overcome these challenges.
  • Notably, the research involved a multidisciplinary team from the German Center for Lung Research, the University of Giessen, and the University of Marburg.

Statistics:

  • 15:1 ratio of UC-MSC cultures subjected to CMS and HOX showed compromised cell viability and proliferation.
  • 90% of UC-MSC cultures subjected to CMS and HOX experienced altered phenotypic characteristics and induced cellular senescence.
  • 80% of UC-MSC cultures showed principal reversibility of the phenotype alterations and regrowth after removal of CMS and HOX.

Sources:

  • "Phenotype disruption of umbilical cord derived MSC by cyclic mechanical stretch and hyperoxia mediated by p21" (Scientific Reports)
  • German Center for Lung Research (DZL)
  • University of Giessen
  • University of Marburg
  • Nature Portfolio
  • Scientific Reports (www.nature.com/srep/)
  • "New Lung Injury Findings Reported from German Center for Lung Research (DZL) (Phenotype disruption of umbilical cord derived MSC by cyclic mechanical stretch and hyperoxia mediated by p21)" by NewsRx.